Salah-Eddine Bentebibel

5PUBLICATIONS
49CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cellular immunologyTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 21, 2026
Intratumoral Sotigalimab with Pembrolizumab Induces Rapid Activation of Antigen-Presenting Cells and Drives Antitumor Responses in Non-injected Tumors in Metastatic Melanoma: A Phase I/II Study.

|Jul 16, 2021
Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC.

Bita Sahaf, Mina Pichavant, Brian H Lee

|Mar 12, 2021
Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma.

Cara Haymaker, Daniel H Johnson, Ravi Murthy

|May 23, 2020
Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02).

Adi Diab, Nizar M Tannir, Salah-Eddine Bentebibel

|Apr 17, 2019
A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors.

Salah-Eddine Bentebibel, Michael E Hurwitz, Chantale Bernatchez

Pageof 1

Frequent Collaborators

5 joint publications

Cara Haymaker

4 joint publications

Chantale Bernatchez

3 joint publications

Douglas B Johnson

2 joint publications

Courtney W Hudgens